Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 18,220 shares at $13.82 ($252K) on 2017-01-10, disclosed to the SEC on 2017-01-13.
Open-market sale of $252k STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.82 | 9,110 | $126K | 50.0% |
| 2 | $13.82 | 9,110 | $126K | 50.0% |
| Total | $13.82 avg | 18,220 | $252K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |